Pfizer (PFE) Tops Q4 EPS by 7c; Guides FY 23 Below the Street
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $27.49 -0.54%
EPS Growth %: -12.6%
Financial Fact:
Discontinued operations--net of tax (in dollars per share): 0
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: -12.6%
Financial Fact:
Discontinued operations--net of tax (in dollars per share): 0
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q4 EPS of $1.14, $0.07 better than the analyst estimate of $1.07. Revenue for the quarter came in at $24.29 billion versus the consensus estimate of $24.61 billion.
GUIDANCE:
Pfizer sees FY2023 EPS of $3.25-$3.45, versus the consensus of $4.44. Pfizer sees FY2023 revenue of $67-71 billion, versus the consensus of $74.13 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Circle Internet stock climbs on TD Cowen upgrade, Fed rate hike
- Barclays says AI trade is maturing, favors greater diversification
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
